Related Experiment Videos
Congenital supravalvar aortic stenosis: a simple lesion?
1Department of Cardiac Surgery, Children's Hospital Boston, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA. stamm_c@hub.tch.harvard.edu
Summary
Congenital supravalvular aortic stenosis (SVAS) is caused by elastin gene mutations, leading to obstructive arteriopathy. This review covers SVAS pathogenesis and surgical implications beyond aortic narrowing.
Area of Science:
- Genetics
- Cardiovascular Medicine
- Developmental Biology
Background:
- Congenital supravalvular aortic stenosis (SVAS) is a rare genetic disorder.
- The elastin gene mutation on chromosome 7q11.23 is the identified cause of SVAS.
- SVAS results in obstructive arteriopathy, primarily affecting the aortic sinutubular junction.
Purpose of the Study:
- To review recent advances in understanding SVAS pathogenesis.
- To describe clinically relevant pathologic features of SVAS.
- To highlight implications for surgical therapy.
Main Methods:
- Literature review of recent advances in SVAS research.
- Analysis of genetic and pathologic findings in SVAS.
- Correlation of pathologic features with surgical considerations.
Main Results:
- Elastin gene loss-of-function mutations cause SVAS.
- The disease manifests as a generalized arteriopathy affecting multiple arteries.
- Stenosis at the aortic valve commissures impacts valve function and coronary circulation.
Conclusions:
- Understanding SVAS pathogenesis is crucial for effective management.
- SVAS involves more than just supra-aortic narrowing, requiring comprehensive surgical approaches.
- Recent advances provide insights into the complex pathology of SVAS.